[The current feature of the study on human coagulation factor IX mutant]

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Context:

• Hemophilia B is an X-linked inherited bleeding disorder.
• It stems from mutations in the human coagulation factor IX (hFIX) gene on the X chromosome.
• These mutations lead to reduced hFIX levels or activity, impairing the intrinsic clotting pathway.

Purpose:

• To review the structure and function of the hFIX gene and its encoded protein.
• To describe various hFIX mutations found in hemophilia B patients.
• To discuss the biological effects of these mutations.

Summary:

• The article details hFIX gene structure, function, and mutations causing hemophilia B.
• Mutations include those in regulatory regions, coding regions, splicing sites, and founder effect-related mutations.
• The biological consequences of these genetic alterations are examined.

Impact:

• Understanding hFIX mutations aids in diagnosing and managing hemophilia B.
• Identifies specific mutations affecting clotting factor activity.
• Highlights a unique mutation (Arg338Ala) that enhances hFIX clotting activity, suggesting potential therapeutic applications.